BreatheIN: Realising the Clinical Potential of Oligonucleotide Rx for Respiratory Disease

Sterghios Moschos

    Research output: Contribution to conferenceOtherpeer-review

    Original languageEnglish
    Publication statusPublished - 1 Feb 2017
    EventMedImmune & AstraZeneca joint presentation - Cambridge, United Kingdom
    Duration: 1 Feb 20171 Feb 2017

    Seminar

    SeminarMedImmune & AstraZeneca joint presentation
    Country/TerritoryUnited Kingdom
    CityCambridge
    Period1/02/171/02/17

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this